@Krylastocksjob Been through this rodeo before. The YTD gains were wild, but NAND demand always feels like a hype rollercoaster. Pullback or not, I'm waiting for earnings to shake out before jumping back in.
$SNDK just got absolutely smoked today -15% or so.
$MU -12%, $WDC -12%...
Not the best of days in the memory/storage crew. After that insane YTD run (over 500%+ at peaks), profit-taking hitting hard? Or is this the healthy pullback before next leg up on NAND demand and 10th-gen flash production news?
Forward P/E still looking reasonable vs. broader tech frenzy. Watching the 50DMA closely β bunch of these names slipping under it. Make it make sense why Sandisk always moves with Micron's shadow but gets the extra volatility spice.
Brute strength earlier, now testing the bulls. Thoughts?
My July tips:
β’ $TSLA β Stay away
β’ $HOOD β Skip it
β’ $AMD β Pass
β’ $MSFT β Grab at $375β$382
β’ $META β Snag at $590β$600
β’ $NVDA β Buy at $192β$198
β’ $RKLB β Pick up at $78β$82
β’ $IONQ β Get at $40β$43
People are sleeping on these stocks. π
$ASTS should be $1000, it's at $75
$NBIS should be $500, it's at $220
$AAOI should be $450, it's at $123
$HIMS should be $100, it's at $36
$OSCR should be $50, it's at $31
$ONDS should be $20, it's at $7
These aren't guesses β
Market sold off on Iran/oil news, but software and AI infrastructure stocks stayed strong. The takeaway? Adding on dips works way better than chasing breakouts. Quality tech holds up when fear is highest. Watching $DDOG and $SNOW for possible setups.
Zuckerberg's talking about getting into AI cloud business β and that's a huge long-term move. Meta's using its massive user base and infrastructure to take on AWS, Azure, and GCP.
Key points:
Huge ad profits funding AI growth
New cloud revenue potential
Buy $META on dips
Forget about chasing those super-hot memory chip stocks...
Try these 5 with the same huge potential instead:
$OUST ~ Ouster
$ZETA ~ Zeta Global
$PLTR ~ Palantir
$NOW ~ ServiceNow
$FCEL ~ FuelCell Energy
Save this post. You'll be glad you did. Early movers cash in big!
Stick with the big names and hold for the long haul. Short-term trading isn't for most people unless you've got guidance or plan to quit after one win. π₯
Here's my top 10 US stocks that could pop next week π
$NVDA $MU $AMD $AVGO $META $INTC $TSLA $MSFT $AMZN $NBIS
AI is sti
$ASTS worth $1K currently at $75
$NBIS worth $500 at $220
$AAOI worth $450 at $123
$HIMS worth $100 at $36
$OSCR worth $50 at $31
$ONDS worth $20 at $7
Not just dreams β these are actual price targets. The market hasn't priced them in yet. Get in before they take off. π
NEW ARTICLE: METHYLENE BLUE in BREAST CANCER - massive cancer cell killing achieved in this ground-breaking 2017 study
Methylene Blue Week continues! π
Now this was a heck of a study! Bet your Oncologist never told you about this one...
2017 Dos Santos et al - Methylene blue photodynamic therapy induces selective and massive cell death in human breast cancer cells
"In this study, we assessed the cell-killing potential of PDT using methylene blue (MB-PDT) in three breast epithelial cell lines... Cells were incubated in the absence or presence of MB and irradiated or not at 640 nm with 4.5 J/cm2"
"We observed that MB-PDT differentially induces massive cell death of tumour cells. Non-malignant cells were significantly more resistant to the therapy compared to malignant cells"
"The highest sensitivity to MB-PDT was observed in MDA-MB-231 cells, used as a model of TNBC (Triple Negative Breast Cancer), a tumour subtype for which there are no targeted treatments"
TNBC cells have lowest reduced glutathione levels compared to all other cell lines - this could be related to the inability of these cells to cope with MB-PDT-induced oxidative stress.
My Take...Highlights:
Methylene Blue targets breast cancer cells but not normal breast cells
Methylene Blue Photodynamic Therapy induces massive cell death of breast cancer cells but only weakly affects normal cells
Triple Negative Breast Cancer cells are most sensitive to killing by Methylene Blue
Multiple cell killing mechanisms are at play but donβt involve mitochondria...Methylene Blue localized not in mitochondria but in lysosomes.
Methylene Blue could be used as an adjunct to breast cancer surgery to βeliminate microscropic residual malignant cells in the post-surgical tumor bed and prevent local as well as metastatic recurrence without affecting normal tissuesβ
Methylene Blue Photodynamic Therapy could replace Radiation Treatment after breast cancer surgery. (!!)
This was a huge discovery. It was then promptly buried and never spoken of in Oncology again.
Because there is no money in Methylene Blue. π€
Those cancer cell killing graphs are stunning!
Have a look! 100% Cancer Cell killing in some cases...
Especially for Triple Negative Breast Cancer!!
(blue bars are normal breast cells, black are breast cancer, red are TNBC)
Methylene Blue week continues...and there are even more shocking articles to come!! Stay tuned! π
Article Link in photo to avoid shadowban, just re-type the URL in the first photo at the top, into your browser to access.
@joerogan
Ep. 70 Governments colluded to shut down and destroy Russell Brand. This is his first interview since that happened. Watch it when you get a minute. It's one of the most brilliant explanations of the modern world you'll ever hear.